Sabra Total Current Liabilities from 2010 to 2025
| SBRA Stock | USD 17.54 0.16 0.92% |
Total Current Liabilities | First Reported 2010-09-30 | Previous Quarter 1.8 B | Current Value 1.8 B | Quarterly Volatility 313.5 M |
Check Sabra Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sabra Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 121.5 M, Interest Expense of 86.1 M or Selling General Administrative of 31.2 M, as well as many indicators such as Price To Sales Ratio of 9.78, Dividend Yield of 0.0646 or PTB Ratio of 1.53. Sabra financial statements analysis is a perfect complement when working with Sabra Healthcare Valuation or Volatility modules.
Sabra | Total Current Liabilities |
Latest Sabra Healthcare's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Sabra Healthcare REIT over the last few years. Total Current Liabilities is an item on Sabra Healthcare balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Sabra Healthcare REIT are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Sabra Healthcare's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sabra Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Sabra Total Current Liabilities Regression Statistics
| Arithmetic Mean | 302,949,100 | |
| Geometric Mean | 105,841,972 | |
| Coefficient Of Variation | 194.77 | |
| Mean Deviation | 375,998,675 | |
| Median | 102,523,000 | |
| Standard Deviation | 590,062,254 | |
| Sample Variance | 348173.5T | |
| Range | 1.8B | |
| R-Value | 0.64 | |
| Mean Square Error | 218872.6T | |
| R-Squared | 0.41 | |
| Significance | 0.01 | |
| Slope | 79,675,559 | |
| Total Sum of Squares | 5222601.9T |
Sabra Total Current Liabilities History
About Sabra Healthcare Financial Statements
Sabra Healthcare stakeholders use historical fundamental indicators, such as Sabra Healthcare's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Sabra Healthcare investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sabra Healthcare's assets and liabilities are reflected in the revenues and expenses on Sabra Healthcare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sabra Healthcare REIT. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 1.8 B | 1.9 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Sabra Healthcare Correlation against competitors. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.827 | Dividend Share 1.2 | Earnings Share 0.54 | Revenue Per Share | Quarterly Revenue Growth 0.125 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.